Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults
NCT: NCT05923827 · COMPLETED
Реклама
NCT IDNCT05923827
СтатусCOMPLETED
Дата начала2023-09-11
Завершение2026-02-12
Краткое описание
This study is a randomized, controlled trial to evaluate the efficacy and safety of the Omnipod® 5 System with the FreeStyle Libre 2 continuous glucose monitor compared to Multiple Daily Injections (MDI) along with the FreeStyle Libre 2 continuous glucose monitor in children and adults with type 1 diabetes.
Официальный источник
Открыть на ClinicalTrials.gov →Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.